The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 47 | — | 20.1x | Near average | |
Growth | 44 | — | 5.6% | Near average | |
Quality | 3 | -289.0% | 7.6% | Below average | |
Safety | 33 | 0.2x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Genelux Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Genelux Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The forecast analysis for Genelux shows complete stability in the average price target at $17.33 over the past 30 days, with a significant gap between the current price ($2.92) and the lowest analyst estimate ($16). This discrepancy reflects excessive optimism from the analysts covering the stock (only 2 in number); however, this optimism has not translated into any recent upward or downward revisions, indicating a state of wait-and-see for tangible results.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.